Sertraline Dosing and Monitoring
Start sertraline at 50 mg once daily in adults, which is both the starting dose and the optimal therapeutic dose for most patients. 12
Starting Dose
- Adults (depression/OCD): 50 mg once daily 1
- Children (6-12 years, OCD only): 25 mg once daily 11
- Adolescents (13-17 years, OCD only): 50 mg once daily 11
The medication can be taken at any time of day, with or without food, though food slightly delays peak concentration from 5.9 to 7 hours 1. This delay is clinically insignificant.
Titration Schedule
For patients not responding adequately within 2-4 weeks, increase the dose in 50 mg increments at intervals of no less than one week to a maximum of 200 mg/day 12. The mean effective dose in clinical trials was approximately 145-186 mg/day for completers 1.
Critical timing consideration: Steady-state plasma concentrations are reached after approximately 7 days in younger adults and 2-3 weeks in elderly patients 13. Do not increase doses more frequently than weekly intervals to allow for pharmacokinetic equilibration.
Special Populations
Elderly Patients (≥65 years)
Use the standard 50 mg starting dose without reduction 42. Despite 40% lower plasma clearance in elderly patients, no dose adjustment is recommended at initiation 11. However:
- Monitor closely for hyponatremia (most common serious adverse event in this age group) 5
- Watch for increased fall risk due to dizziness and electrolyte disturbances 5
- Steady-state takes 2-3 weeks (versus 1 week in younger adults) 1
- Sertraline is a preferred SSRI for elderly patients alongside citalopram, escitalopram, and mirtazapine 4
Important caveat: Elderly patients show 2-fold higher rates of supratherapeutic drug levels (6.7% vs 3.4% in younger patients) despite receiving similar doses 6. Consider therapeutic drug monitoring if adverse effects emerge, though routine TDM is not established 7.
Hepatic Impairment
Use a lower or less frequent dose in any degree of liver impairment 11. In mild hepatic impairment (Child-Pugh 5-8), sertraline clearance is reduced, resulting in approximately 3-fold greater drug exposure 11.
Practical approach:
- Start at 25 mg daily or 50 mg every other day
- Titrate more slowly than in patients with normal hepatic function
- Effects in moderate-to-severe hepatic impairment are unstudied; use extreme caution 1
Renal Impairment
No dose adjustment needed for any degree of renal impairment, including patients on hemodialysis 11. Sertraline undergoes extensive hepatic metabolism with minimal renal excretion of unchanged drug.
Monitoring Parameters
Timing of Adverse Events
26.77% of adverse reactions occur within the first week of treatment 5, with the median time to onset of drug-induced liver injury within the first month 8. This necessitates close early monitoring.
Essential Monitoring
First month (weekly contact recommended):
- Suicidal ideation/behavior, especially in patients <25 years 1
- Activation symptoms (agitation, restlessness, insomnia)
- Liver enzymes if risk factors present (baseline abnormalities, concurrent hepatotoxic drugs) 8
- Sodium levels in elderly patients 5
Ongoing monitoring:
- Weight in pediatric patients: Regular monitoring is essential as 7% of children experienced >7% body weight loss in trials (versus 0% on placebo) 1. Weight gain typically resumes after 12 weeks of treatment 1
- Bleeding risk if on anticoagulants or NSAIDs
- Sexual dysfunction (common but underreported)
- Serotonin syndrome symptoms if combining with other serotonergic agents
Newly Identified Safety Signals
Beyond established adverse events, recent pharmacovigilance data identified signals for 5:
- Bruxism (teeth grinding)
- Genital anesthesia
- Microscopic colitis
Critical Drug Interactions
Absolute contraindications:
Requires close monitoring:
- Other serotonergic agents (risk of serotonin syndrome, even at 25 mg dose) 9
- Lithium (pharmacodynamic interaction causing increased tremor) 3
- Warfarin (monitor INR closely) 3
Common pitfall: A case report documented serotonin syndrome in a 75-year-old woman within 14 hours of starting sertraline 25 mg (the minimum dose) when combined with sulpiride, despite no traditional high-risk combinations 9. This emphasizes that elderly patients require heightened vigilance even at starting doses.
Duration of Treatment
Minimum 4 months for first episode of major depression 4. Patients with recurrent depression benefit from prolonged or indefinite treatment 4. In the continuation study, patients maintained on sertraline 50-200 mg/day (mean 70 mg/day) showed significantly lower relapse rates over 44 weeks compared to placebo 1.
Pediatric Considerations
Sertraline is FDA-approved only for OCD in children aged 6-17 years 1. Two placebo-controlled trials in pediatric major depressive disorder failed to demonstrate efficacy 1. Pediatric patients metabolize sertraline approximately 22% more efficiently than adults when adjusted for weight, but lower absolute doses are still recommended due to smaller body mass 11.